MET and rhabdomyosarcoma: Previous studies indicated that elevated doses of crizotinib can induce autophagy in alveolar rhabdomyosarcoma cells [36] and that autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells [23].